Breaking News
The AI Bird-Flu Scenario They Just Published
Japan's first robot ambulance works the 9-1-1 lines for humanoids
Cheap smartphone add-on pinpoints hidden cameras to shut down spies
The $600 Tank That Beats a $10,000 Powerwall
Top Tech News
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Epidemiologist Nicolas Hulscher on Brannon Howse Live
Yesterday, I joined Brannon Howse Live to share some long-overdue good news. We discussed emerging breakthroughs in cancer research, the extraordinary promise of natural compounds like dandelion root and high-dose vitamin C, and a major development in the mRNA arena:
Dandelion Root Extract: A Common Weed With Anti-Cancer Power
·
Dec 9
A remarkable peer-reviewed study found that aqueous dandelion root extract kills 95% of cancer cells in vitro and reduces human colon tumor growth by over 90% in mice — with zero toxicity.
Tumors in untreated mice grew aggressively.
Tumors in the treated group barely grew at all.
Human trials were planned but mysteriously never funded — likely because a common backyard plant is not profitable for the chemo-industrial complex.
This study fits into a larger body of over 1,100 peer-reviewed papers showing anti-cancer effects from natural, non-toxic compounds — an entire therapeutic frontier long ignored because it threatens the economics of conventional oncology.